Natus Medical Inc
NTUSDelisted Jul 21, 2022- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000878526
Natus Medical Inc was delisted on Jul 21, 2022; its insiders filed their last Form 4 on Jul 21, 2022; 187 institutions reported holding it in 13F filings for Q2 2022, worth $1.07B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Natus Medical Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Natus Medical Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Levine Joshua | Director | 0 | Jul 21, 2022 | 0 |
| Chung Dong Chune Christopher | Chief Medical Officer | 0 | Jul 21, 2022 | 0 |
| Daskal Ilan | Director | 0 | Jul 21, 2022 | 0 |
| Sullivan Thomas Joseph | President and CEO | 0 | Jul 21, 2022 | 0 |
| Noll Austin Francis III | Executive VP and CCO | 0 | Jul 21, 2022 | 0 |
| Davies Benjamin Drew | Executive VP and CFO | 0 | Jul 21, 2022 | 0 |
| Heine Lisa Wipperman | Director | 0 | Jul 21, 2022 | 0 |
| Schroeder Alice D. | Director | 0 | Jul 21, 2022 | 0 |
| Guerin Eric | Director | 0 | Jul 21, 2022 | 0 |
| Moore Bryant M | Director | 0 | Jul 21, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 (view filing) | Dec 9 | 4 days | Chung Dong Chune ChristopherChief Medical Officer | SSaleCommon Stock, $0.001 par value per share | −11.8K | $23.08 | −$272.0K | −22.8%39.9K after |